Waters Corporation $WAT Shares Bought by HB Wealth Management LLC

Posted by Brenda Bartman on Jul 8th, 2026

HB Wealth Management LLC grew its position in Waters Corporation (NYSE:WAT – Free Report) by 165.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,198 shares of the medical instruments supplier’s stock after purchasing an additional 2,614 shares during the quarter. HB Wealth Management LLC’s holdings in Waters were worth $1,250,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in WAT. Fundsmith LLP boosted its position in shares of Waters by 9.6% in the 3rd quarter. Fundsmith LLP now owns 3,955,498 shares of the medical instruments supplier’s stock worth $1,185,898,000 after purchasing an additional 347,091 shares in the last quarter. Geode Capital Management LLC increased its position in Waters by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 1,593,388 shares of the medical instruments supplier’s stock valued at $602,921,000 after buying an additional 8,590 shares in the last quarter. Invesco Ltd. raised its stake in Waters by 32.3% in the third quarter. Invesco Ltd. now owns 1,472,419 shares of the medical instruments supplier’s stock valued at $441,446,000 after buying an additional 359,596 shares during the last quarter. Fundsmith Investment Services LTD. boosted its holdings in Waters by 11.1% in the third quarter. Fundsmith Investment Services LTD. now owns 1,356,289 shares of the medical instruments supplier’s stock worth $406,629,000 after acquiring an additional 135,504 shares in the last quarter. Finally, Veritas Asset Management LLP boosted its holdings in Waters by 112.3% in the fourth quarter. Veritas Asset Management LLP now owns 1,241,206 shares of the medical instruments supplier’s stock worth $471,447,000 after acquiring an additional 656,436 shares in the last quarter. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Waters Stock Performance

Shares of NYSE WAT opened at $374.94 on Wednesday. The company has a 50 day simple moving average of $354.18 and a two-hundred day simple moving average of $346.74. The stock has a market cap of $36.82 billion, a price-to-earnings ratio of 47.64, a PEG ratio of 2.29 and a beta of 1.20. The company has a current ratio of 1.79, a quick ratio of 1.13 and a debt-to-equity ratio of 0.32. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $414.15.

Waters (NYSE:WAT – Get Free Report) last issued its earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.31 by $0.39. Waters had a net margin of 11.91% and a return on equity of 15.60%. The firm had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.20 billion. During the same quarter last year, the company posted $2.25 earnings per share. The firm’s revenue was up 91.4% compared to the same quarter last year. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. As a group, analysts predict that Waters Corporation will post 14.51 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Waters in a report on Monday, April 20th. TD Cowen lifted their target price on shares of Waters from $345.00 to $385.00 and gave the stock a “hold” rating in a research note on Wednesday, May 6th. JPMorgan Chase & Co. boosted their target price on shares of Waters from $330.00 to $345.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. The Goldman Sachs Group raised shares of Waters to a “strong-buy” rating in a report on Wednesday, April 1st. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $350.00 price objective on shares of Waters in a report on Thursday, May 7th. Four analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $399.84.

Read Our Latest Report on Waters

Waters Profile

(Free Report)

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.

Waters Corporation $WAT Shares Bought by HB Wealth Management LLC

Waters Stock Performance

Analyst Ratings Changes

Waters Profile

See Also

You might be interested in: